IL33 and neoplasm: In contrast, IL‐33 exhibits antitumor properties in B16 melanoma, 3LL, and 4 T1 mammary tumor models by enhancing the cytotoxicity and tumor infiltration of cytotoxic T cells and natural killer cells [24, 25].